InvestorsHub Logo
Followers 24
Posts 1944
Boards Moderated 0
Alias Born 07/07/2014

Re: a surfer post# 328

Thursday, 12/22/2016 12:13:25 PM

Thursday, December 22, 2016 12:13:25 PM

Post# of 2676
Yeah, some good points in this article too:

http://www.streetinsider.com/Analyst+Comments/Cantor+Fitzgerald+Starts+Zynerba+Pharmaceuticals+(ZYNE)+at+Overweight/12364738.html

"We believe success in the refractory epilepsy program is strongly supported by recent oral CBD data in orphan pediatric epilepsies achieved by GW Pharmaceuticals (GWPH – Overweight). Furthermore, the delivery of CBD through the skin, avoiding first pass metabolism by the liver, could represent a significant advantage, in our view"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News